N95 Reuse During COVID-19
NCT05148793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412
Last updated 2023-02-16
Summary
During critical personal protective equipment (PPE) shortages, such as those associated with the COVID-19 pandemic, Centers for Disease Control (CDC) recommends N95 extended use (wearing the same N95 for multiple patient encounters) and limited reuse (storing an N95 between shifts for use over multiple shifts with or without decontamination) as contingency and crisis capacity strategies, respectively. Many healthcare workers (HCWs) are employing these strategies out of necessity. The sustained performance of these respirators depends on the respirator maintaining its filtration efficiency and its ability to provide an adequate seal (fit) to the user's face. Fit testing is performed when a respirator is issued to the user and on an annual basis thereafter. A user-seal check is then performed whenever a respirator is donned. Previous studies have found repeated donnings/doffings to significantly decrease the respirator's fit. A recent pilot cross-sectional clinical study conducted by the University of California, San Francisco found fit failures of respirators after being worn for 2 shifts. However, more definitive data regarding respirator performance during reuse and extended use are lacking. The investigators plan to address these critical gaps in knowledge by conducting a prospective cohort study to determine the incidence of N95 fit failure when subjected to extended use/reuse in a clinical setting. The investigators plan to enroll 396 ED providers (including physicians, nurses, and staff) when obtaining a new NIOSH approved N95s and performing serial fit tests at the end of each 8-12 hour shift for up to 5 clinical shifts or until N95 failure, whichever is earlier. By carefully measuring fit test failure in a clinical setting, the investigators will be able to provide guidance regarding the safety of N95 extended use and reuse necessitated by the need for PPE conservation. Specifically, the investigators will address the following research questions: 1) how long N95s maintain their fit during extended use, 2) how many times N95s can be donned/doffed and maintain their fit, 3) the ability of a user seal check to indicate fit in the field, 4) what adverse health effects, reports of discomfort, or symptoms are experienced by users during extended use and reuse, 5) what effect does extended use and reuse have on N95 filtration performance, 6) the level of contamination of N95s when subjected to extended use and reuse, 7) the effect of modifications to N95 (covering an N95 with a face shield or surgical N95s, facial coverings) on fit failure.
Conditions
- Emergency Medicine
- Frontline Providers
- Healthcare Worker
Sponsors & Collaborators
-
University of California, San Diego
collaborator OTHER - collaborator OTHER
-
University of Wisconsin, Madison
collaborator OTHER -
Emory University
collaborator OTHER -
University of Rochester
collaborator OTHER -
Centers for Disease Control and Prevention
collaborator FED -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Maria C Raven, MD · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- United States
Study Locations
More Related Trials
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
Thumbtack Needle in the Treatment of NVP
NCT06566274 ·Status: RECRUITING ·Phase: NA
-
Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department
NCT02760069 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat
NCT04644705 ·Status: COMPLETED ·Phase: PHASE1
-
Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department
NCT04464915 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo
NCT02253524 ·Status: COMPLETED ·Phase: PHASE4
-
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
NCT04219982 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent
NCT01418157 ·Status: COMPLETED ·Phase: PHASE4
-
Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting
NCT02457195 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
NCT01953081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00492037 ·Status: COMPLETED ·Phase: PHASE3
-
The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
NCT02657031 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness
NCT04272255 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
NCT05342818 ·Status: COMPLETED ·Phase: PHASE2
-
Cortical Excitability in Cyclic Vomiting Syndrome
NCT05256160 ·Status: RECRUITING ·Phase: NA
-
A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department
NCT00429832 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of TAK-105 in Healthy Adults
NCT04964258 ·Status: COMPLETED ·Phase: PHASE1
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
NCT05852730 ·Status: RECRUITING ·Phase: PHASE2
-
Re-examination Study of EMEND (Aprepitant) (MK-0869-184)
NCT01074255 ·Status: COMPLETED
-
Sickness Evaluation at Altitude With Acetazolamide at Relative Doses
NCT03828474 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Potentially Inappropriate Medication Prescribing for Older Patients in the ED
NCT04004936 ·Status: COMPLETED ·Phase: NA
-
Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
NCT00878228 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED
NCT00655642 ·Status: TERMINATED ·Phase: NA
-
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
NCT04184115 ·Status: COMPLETED ·Phase: PHASE3